08/01/2021
Marina Urena, MD; Antonio Munoz-Garcia, MD; Gabriela Veiga-Fernandez, MD; Vicenç Serra; Quentin Fischer, MD; Dominique Himbert, MD; Erika Munoz-Garcia, MD; Rafael Vera-Urquiza, MD; Laurent Faroux, MD, MSc; Isaac Pascual, MD; Lucia Junquera, MD; Bruno Garcia Del Blanco, MD; Josep Rodés-Cabau, MD, PhD; Siamak Mohammadi, MD; Melanie Côté, MD, MSc; Benjamin Faurie, MD, PhD; Luis Nombela-Franco, MD; Pilar Jimenez-Quevedo, MD; Alberto Alperi, MD, PhD; Thomas Couture, MS; Jose de la Torre Hernandez, MD, PhD
Vascular and bleeding complications related to secondary femoral access site are frequent in patients undergoing TAVR, and their occurrence is associated to poorer outcomes. We aimed to evaluate the clinical impact of VCDs for secondary...
Vascular and bleeding complications related to secondary femoral access site are frequent in patients undergoing TAVR, and their occurrence is associated to poorer outcomes. We aimed to evaluate the clinical impact of VCDs for secondary...
Vascular and bleeding...